Clinical trial · Interventional
ioMRI in the Surgery of Brain Metastases.
Evaluation of the Efficacy and Safety of Intraoperative MRI in the Surgery of Brain Metastases.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical outcomes and reduce the need for additional procedures. While iMRI offers the promise of better tumor visualization during surgery, it is also associated with longer surgical times and may carry the risk of increased complications. This study seeks to carefully evaluate these aspects to determine the overall benefits and challenges of iMRI in brain metastasis surgeries. The ultimate aim is to enhance treatment effectiveness and improve recovery and health outcomes for participants dealing with brain metastases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Metastases | Brain Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgery with intraoperative MRI | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Surgery without intraoperative MRI
- type
- EXPERIMENTAL
- label
- Surgery with intraoperative MRI
- interventionNames
- Procedure: Surgery with intraoperative MRI
Primary outcomes (1)
- measure
- Rate for complete resection
- timeFrame
- immediately after the surgery
- description
- The postoperative MRI obtained within 72 hours after surgery will be analyzed to identify the rates of resection.
Secondary outcomes (1)
- measure
- Complications
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients for whom surgical resection of brain metastasis is indicated Exclusion Criteria: * age \< 18 * 3T MRI contraindications
References
Publications (0)
Data not yet available